Neuroblastoma trials in United States

In United States 60 Also abroad 129

60 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
Where
Palo Alto
Age
2 years to 30 years
People
41
Run by
Stanford University
See details and how to joinNCT06500819
Phase 1Taking people
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Where
Valhalla
Age
1 year to 30 years
People
30
Run by
New York Medical College
See details and how to joinNCT04308330
Phase 1Taking people
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
Where
Atlanta, Chapel Hill
Age
18 months and over
People
18
Run by
UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT03721068
No phaseTaking people
Neuroblastoma Biology Study
Where
Ann Arbor, Atlanta, Aurora, Boston, Chapel Hill, Chicago, Cincinnati, Columbus, Dallas, Fort Worth, Los Angeles, Memphis, Palo Alto, Philadelphia, San Francisco, Seattle
Age
31 days to 99 years
People
1,000 worldwide
Run by
New Approaches to Neuroblastoma Therapy Consortium
See details and how to joinNCT01587300
Phase 2Taking people
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Where
Baltimore, The Bronx, Valhalla
Age
1 year to 50 years
People
60
Run by
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT01804634
No phaseTaking people
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
Where
Atlanta, Boston, Dallas, Hartford, Philadelphia, Seattle
Age
Up to 17 years
People
84
Run by
Dana-Farber Cancer Institute
See details and how to joinNCT06831552
Phase 1Taking people
Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
Where
Atlanta
Age
12 months and over
People
24
Run by
Emory University
See details and how to joinNCT05400603
Phase 1/2Taking people
Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
Where
Boston
Age
12 months to 29 years
People
42
Run by
Roberto Chiarle
See details and how to joinNCT06803875
No phaseTaking people
Molecular Analysis Of Solid Tumors
Where
Memphis
Age
Up to 25 years
People
1,000
Run by
St. Jude Children's Research Hospital
See details and how to joinNCT01050296
Phase 2Taking people
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Where
Aurora, Birmingham, Columbus, Salt Lake City, The Bronx, Washington D.C.
Age
18 months to 40 years
People
86
Run by
Nationwide Children's Hospital
See details and how to joinNCT05135975